EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients

Ayman Al Saati iD, Pierre Vande Perre iD, Julien Plenecassagnes, Julia Gilhodes, Nils Monselet, Bastien Cabarrou, Norbert Lignon, Thomas Filleron, Dominique Telly, Emilie Perello-Lestrade, Viviane Feillel, Anne Staub und 6 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ayman Al Saati und 17 weiteren Autor:innen. Beteiligte Einrichtung: Oncogenetics Laboratory, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France. Hauptthemen laut MEDLINE: Germ-Line Mutation, Breast Neoplasms, Male. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue Contre le Cancer (comités 31 and 65).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Even though male breast cancer (MBC) risk encompasses both genetic and environmental aetiologies, the primary risk factor is a germline pathogenic variant (PV) or likely pathogenic variant (LPV) in BRCA2, BRCA1 and/or PALB2 genes. To identify new potential MBC-specific predisposition genes, we sequenced a panel of 585 carcinogenesis genes in an MBC cohort without BRCA1/BRCA2/PALB2 PV/LPV. We identified 14 genes carrying rare PVs/LPVs in the MBC population versus noncancer non-Finnish European men, predominantly coding for DNA repair and maintenance of genomic stability proteins. We identified for the first time PVs/LPVs in PRCC (pre-mRNA processing), HOXA9 (transcription regulation), RECQL4 and WRN (maintenance of genomic stability) as well as in genes involved in other cellular processes. To study the specificity of this MBC PV/LPV profile, we examined whether variants in the same genes could be detected in a female breast cancer (FBC) cohort without BRCA1/BRCA2/PALB2 PV/LPV. Only 5/109 women (4.6%) carried a PV/LPV versus 18/85 men (21.2%) on these genes. FBC did not carry any PV/LPV on 11 of these genes. Although 5.9% of the MBC cohort carried PVs/LPVs in PALLD and ERCC2, neither of these genes were altered in our FBC cohort. Our data suggest that in addition to BRCA1/BRCA2/PALB2, other genes involved in DNA repair/maintenance or genomic stability as well as cell adhesion may form a specific MBC PV/LPV signature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationBreast Neoplasms, MaleHumansMaleGenetic Predisposition to DiseaseMiddle AgedFemaleBRCA2 ProteinAgedBRCA1 ProteinAdult

Stichwörter der Autor:innen

MBC-specific mutated profilelarge multigene panel sequencingmale breast cancer predispositionnew genes potentially involved in MBC risk

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA2 protein, humanBRCA1 protein, human

Autor:innen und Institutionen

  • Oncogenetics Laboratory, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • DIAD, Inserm, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.
  • Université de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France.
  • Bioinformatics Department, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Biostatistics Department, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Oncogenetics Department, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.

ORCID-Profile: Ayman Al Saati, Pierre Vande Perre, Fabienne Thomas

Förderung

  • Ligue Contre le Cancer (comités 31 and 65)

Zitieren

APA

Al Saati, A., Vande Perre, P., Plenecassagnes, J., Gilhodes, J., Monselet, N., Cabarrou, B., Lignon, N., Filleron, T., Telly, D., Perello-Lestrade, E., Feillel, V., Staub, A., Martinez, M., Chipoulet, E., Collet, G., Thomas, F., Gladieff, L., & Toulas, C. (2023). Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814348

Vancouver

Al Saati A, Vande Perre P, Plenecassagnes J, Gilhodes J, Monselet N, Cabarrou B, et al. Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814348

BibTeX
@article{AlSaati2023,
  author = {Al Saati, Ayman and Vande Perre, Pierre and Plenecassagnes, Julien and Gilhodes, Julia and Monselet, Nils and Cabarrou, Bastien and Lignon, Norbert and Filleron, Thomas and Telly, Dominique and Perello-Lestrade, Emilie and Feillel, Viviane and Staub, Anne and Martinez, Mathilde and Chipoulet, Edith and Collet, Gaëlle and Thomas, Fabienne and Gladieff, Laurence and Toulas, Christine},
  title = {Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814348}
}
Kostenlos starten →